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RESUMO 
Introdução: Apesar de o mecanismo de imunossupressão associada com a reativação de toxoplasmose em 
pacientes transplantados ser conhecido, a interação entre células humanas e citocinas não está bem estabelecida. Relato: 
Descrevemos um caso de reativação de toxoplasmose em um paciente transplantado renal com pneumonite. A expressão das 
citocinas e os fenótipos celulares foram avaliados neste caso. Resultados: Houve um predomínio do padrão de resposta 
immune Th2, com forte expressão de TGF-beta, TNF-alfa e IL-10. A expressão do receptor de IL-2, oxido nítrico sintetase e IFN-
gama foi fraca. Conclusão: A reativação de toxoplamose no pulmão foi associada a um padrão de resposta imune Th2 e 
atividade macrofágica diminuída. 
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ABSTRACT 
Background: The mechanism of immunosuppression associated with reactivation of the toxoplasmosis in 
transplanted patients is known, but the interactions of the human cells and cytokines expression is not well established. Case 
report:  We described a case of toxoplasmosis reactivation in a renal transplanted patient with pneumonitis. The in situ 
expression of cytokines and cellular phenotypes was evaluated in this case. Results:  A Th2 pattern of immune response 
predominated with strong expression of TGF-beta, TNF-alpha and IL-10. The expression of IL-2 receptor, nitric oxide synthase 
and IFN-gamma were weak. Conclusion: The reactivation of toxoplasmosis in the lung was associated with a Th2 pattern of 
immune response and decreased activity of macrophages.   
 Keywords: Toxoplasmosis. Toxoplasma gondii. Kidney transplantation. Immune response. 
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Post-transplant toxoplasmosis is frequently 
described in heart transplanted patients, but reactivation in 
renal transplanted patients is less common 1, 2. 
Reactivation is the most common cause of the disease in 
this group of patients, although de novo infection can 
occurs. The attributed mortality is high and more than 50% 
of toxoplasmosis reactivation in renal transplantation 
recipients are diagnosed at autopsy1.  
Pneumonia is the second most common 
manifestation of the reactivation, after toxoplasmic 
encephalitis, and both clinical forms occur due to 
immunosuppressive drugs. The mechanism of action of 
these drugs is well understood, but the immune response 
pattern found in the human lung tissue during Toxoplama 
gondii reactivation was not studied. A previous in vitro 
study showed that reactivation of T. gondii infection in 
lungs results from a decrease in Th1 cytokine levels or a 
transient increase in Th2 cytokine levels1.  
The aim of this report is to describe a case of T. 
gondii pneumonia in a renal transplanted patient and 
evaluate the adaptative and innate immune aspects found 




A 66-year-old male patient with chronic renal 
failure secondary to nephrolitiasis was admitted 
asymptomatic for renal transplantation from cadaver 
donor. Patient and donor tests were positive for 
Toxoplasma and cytomegalovirus (ELISA IgG positive and 
IgM negative). Serology of hepatitis (A, B and C), syphilis, 
HIV, Chagas and HTLV were all negative from both. The 
patient received antithymocyte globulin (ATG) for ten days 
and methylprednisolone 500mg for induction therapy, 
followed by daily tacrolimus, prednisone and 
mycophenolate mofetil. Gancyclovir was used for 
cytomegalovirus prophylaxis and 
sulphametoxazol/trimetoprim for toxoplasmosis 
toxoplasmosis since the day of the transplant. In the 20th 
day after transplantation, the patient had fever and cough 
followed by myalgia and dyspnea two days later. One week 
after initial symptoms, the dyspnea progressed to acute 
respiratory failure with severe hypoxemia and death 
overcome despite intensive care. Chest roentgenographs 
were normal when symptoms initiated but diffuse bilateral 
interstitial infiltrates were present in the last day. Blood, 
urine and sputum culture were negatives. An autopsy was 
performed.  
In the histopathological exam, Toxoplasma 
bradyzoites were found in central nervous system without 
inflammatory infiltrate, which is compatible with absence of 
encephalitis. Interstitial pneumonia with septal thickness 
and mononuclear infiltrate were found associated with 
parenchymal necrosis. In these areas, several tachyzoites 
of Toxoplasma were identified by immunohistochemistry 
method. The section was incubated with an anti-T. gondii 
antibody produced in mouse (kindly provided by Instituto 
de Medicina Tropical de São Paulo), diluted 1:400 in 
albumin solution, over-night at 4ºC. Incubations with 
biotinylated anti-mouse antibody and with streptavidin-
biotin-peroxidase complex (Dako, LSAB, Glostrup Denmark) 
were carried out for 30 min at 37°C. The sections were 
counterstained with Mayer-Hematoxylin.  
 
Figure 1. In situ evaluation of cytokines and cellular 
phenotypes in toxoplasma pneumonia through 
immunohistochemistry in lung t issue (400x) 
counterstained with Mayer-Hematoxyl in. Phenotypes 
cel lular compared with normal lung. A) presence of 
antigens to Toxoplasma gondii  in the lung t issue 
rounded by an acute inflammatory infi l trate with septal 
thickness; B) low expression of CD4+ lymphocytes 
compared with control (B1);  C) alveolar macrophages 
infi l trate in toxoplasma pneumonia; D) low expression 
of iNOS by the interstit ial  macrophages. 
 
In situ immune response was studied through 
cytokines analysis and immunohistochemical study for 
phenotype markers. The paraffin-embedded lungs were re-
sectioned and 5 µm sections were adhered to sylane 
treated slides. Sections were submitted to hematoxylin-
eosin (HE) stain and immunohistochemistry with 
monoclonal antibodies revealed by the streptavidin-biotin 
peroxidase method, using endogenous biotin blocking 
system (DAKO, USA) with modifications as elsewhere 
described3. The following monoclonal antibodies for 
cellular phenotypes and cytokines were used in this 
process: CD4 (M834/DAKO, Glostrup Denmark), CD8 
(M7103/DAKO, Glostrup Denmark), CD20 (M755/DAKO, 
Glostrup Denmark), CD68 (M786/DAKO, Glostrup 
Denmark), NK (M1014/DAKO, Glostrup Denmark), IL-2r 
(M731/DAKO, Glostrup Denmark), IL-4 (AB204/R&D 
Systems, Minneapolis, USA), IL-10 (MAB 217/ R&D 
Systems, Minneapolis, USA), IL-12 (MAB 219/R&D 
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Systems, Minneapolis, USA), TNF-β (IP300/Genzyme, 
Boston, USA), and IFN-γ (IP 500/Genzyme, Boston, USA). 
Macrophage activation was determined by evaluation of 
NOS activity using inducible rabbit polyclonal Antibody anti-
nitric oxide synthase (NOS) (PAB 482728/Calbiochem, 
Darmstadt, Germany). This case was compared with a 
control group of normal lungs described elsewhere, using 
semi-quantitative method4.  
In situ immune pattern of response showed an 
increased CD8/CD4 ratio although both were globally 
decreased in comparison with other cells (figure 1). There 
were a large number of intra-alveolar and intra-septal 
macrophages (CD68+). Rare CD20+ cells (B cell 
lymphocytes) and NK cells were present in the tissue. The 
expression of cytokine such as TGF-β, TNF-α and IL-10 was 
increased in extracellular tissue and in macrophages, 
mainly around Toxoplasma cysts. IFN-γ, iNOS and IL-4 





Toxoplasmosis reactivation was formerly 
described in a renal transplanted patient in 1966 and 
represents a severe unrecognized opportunistic infection 
with high mortality1. Two forms of the same T. gondii can 
be present in humans: active tachyzoite and dormant form 
of bradyzoite5. The tachyzoite stage is responsible for 
active infection and expresses antigens that induce a Th1 
pattern of immune response. If inflammatory response is 
adequated, T. gondii differentiates into dormant forms, the 
bradyzoites. The bradyzoites are present as tissue cysts in 
the brain, retina, lung and other organ for all life of the 
host. The maintenance of the tissue cysts with bradyzoites 
occurs due to adequate and continuous IFN-γ production 
and further nitric oxide by activated macrophages, which 
favors transformation of active tachyzoites to bradyzoites6. 
IFN-γ is produced by CD8+ lymphocytes, which are 
activated by CD4+ lymphocytes through IL-2 production. 
Although other cells also produces IFN- γ, as dendritic cells, 
natural killer cells and CD4+ lymphocytes. Any disruption of 
this cascade can interfere with IFN-γ synthesis and loss of 
bradyzoites control7. When low levels of IFN-γ are present 
in the tissue, transformation of bradyzoites to tachyzoites 
occurs, allowing replication of this fast-growing forms and 
further disease reactivation.  
Lung reactivation of toxoplasmosis is clinically 
expressed after the “wake up” of dormant bradyzoites from 
the own pulmonary tissue or, more commonly, as a shock 
organ within the first week of intense parasitaemia of 
tachyzoites from central nervous system migrating to the 
lung.  
We showed, in the case here reported, increased 
expression of TGF-β, TNF-γ and IL-10 with weak expression 
of IL-2r and IFN-γ in the lung tissue. This pattern of 
cytokines is the ideal representation of inflammatory 
pattern of Th2 response8. Low levels of IL-2r decreases 
IFN-γ production by CD8+ lymphocytes. The inhibition of 
IFN-γ does not activate macrophages, allowing tachyzoite 
multiplication9. In animal models, the reactivation of the 
disease is associated with decreased levels of tissue IFN-γ 
and IL-2r with increased levels of interleukin-10 (IL-10) as 
seen in our case10.  
We demonstrated the presence of large number 
of macrophages without expression of NOS (non-activated 
macrophage). The IFN-γ induces NOS which yield nitric 
oxide and further destruction of phagocyted tachyzoites. 
This pattern of immune response found in the lung allowed 
tachyzoite tissue invasion and intense necrosis with the 
organ failure. CD4+ and CD8+ lymphocytes were 
decreased in lung tissue, which could be related with low 
levels of IFN-γ, IL-2 and iNOS. The number of macrophages 
increased, but not activated (low iNOS levels). Intense 
necrosis with increased number of macrophages was found 
in this case. Gazzinelli et al. showed a similar pattern of 
iNOS but with increased levels of Th1 cytokines11.  
Those immunological disorders were caused by 
the immunosuppressive drugs. A previous study evaluated 
the effect antithymocyte globulin on experimental 
toxoplasmosis in mice to get further information about the 
immune mechanisms important in reactivation of 
toxoplasmosis12. The results suggested that treatment with 
ATG may activate a latent Toxoplasma infection and 
aggravate the course of the disease. The decrease of 
lymphocytes CD4+ and CD8+ in the lung tissue of our case 
is compatible with the previous ATG use and the increased 
number of inactivated macrophage with prednisone use.  
Tacrolimus is a calcineurin inhibitor and 
decreases the expression of IL-2 by lymphocytes13 . The 
presence of tachyzoites in the tissue also decreases the 
calcium entry into lymphocytes, decreasing the activity of 
calcineurin and IL-2 synthesis14. Another 
immunosuppressive drug used by our patient, 
mycophenolate mofetil, inhibits inosine-monophosphate 
dehydrogenase enzyme present in lymphocytes, which is 
important in the synthesis of nucleic acids. Although 
mycophenolate can corroborate to toxoplasmosis 
reactivation, it also inhibits the enzyme present in the 




Several aspects of the immune response were 
explored in this case. We could expand some of the 
findings herein described to other situations in renal 
transplant and opportunistic infections. In situ study of 
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immune response by immunohistochemistry is a tool for 
the understanding of the immunopathology of a wide 
variety of infectious diseases, including toxoplasmosis. It 
permits the detection of the types of cells and cytokines 
involved in the inflammatory in situ tissue response, which 
cannot be real using serum inflammatory markers.  
In summary, the reactivation of toxoplasmosis in 
transplanted patients is a serious unrecognized disease 
due to difficult diagnosis and can be explained by the 
immunosuppressive therapy. The immune condition 
associated with this disorder is probably a Th2 pattern of 
response with increased levels of TGF-β and IL-10 with low 
expression of IL-2r and low levels of IFN-γ that are 
expressed by an increased number of inactivated 
macrophages in the lung tissue producing parenchymal 
necrosis. The increased expression of TNF-β suggests 
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